{
    "@context": "https://api.researchmap.jp/researcher.jsonld",
    "@id": "https://api.researchmap.jp/read0166380?format=json",
    "@type": "researchers",
    "rm:user_id": "1000000115",
    "rm:creator_id": "1000000115",
    "rm:creator_type": "myself",
    "rm:created": "2011-03-28T15:00:00Z",
    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
    "rm:modifier_type": "institution",
    "rm:modified": "2022-09-27T00:41:34Z",
    "permalink": "read0166380",
    "family_name": {
        "ja": "小山",
        "ja-Kana": "コヤマ",
        "en": "Koyama"
    },
    "given_name": {
        "ja": "司",
        "ja-Kana": "ツカサ",
        "en": "Tsukasa"
    },
    "display_name_kana": "disclosed",
    "display_nickname": "disclosed",
    "display_image": "disclosed",
    "display_contact_point": "disclosed",
    "affiliations": [
        {
            "affiliation": {
                "ja": "北海道大学",
                "en": "Hokkaido University"
            },
            "section": {
                "ja": "大学院医学研究科 医学専攻 神経病態学講座",
                "en": "Graduate School of Medicine, Division of Medicine"
            },
            "job": {
                "ja": "教授",
                "en": "Professor"
            },
            "display_affiliation": "disclosed",
            "display_job": "disclosed",
            "rm:institution_code": "0100526008"
        }
    ],
    "display_profile": "disclosed",
    "display_url": "disclosed",
    "identifiers": {
        "j_global_id": [
            "200901092713472522"
        ]
    },
    "rm:erad_id_verified": false,
    "rm:orc_id_verified": false,
    "display_erad_id": "closed",
    "display_orc_id": "closed",
    "display_researcher_id": "disclosed",
    "display_j_global_id": "disclosed",
    "see_also": [
        {
            "label": "j_global",
            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=200901092713472522"
        }
    ],
    "@graph": [
        {
            "@id": "https://api.researchmap.jp/read0166380/research_interests",
            "@type": "research_interests",
            "@reverse": "https://api.researchmap.jp/read0166380",
            "total_items": 2,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0166380/research_interests/6319994",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0166380/research_interests",
                    "rm:id": "6319994",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "keyword": {
                        "ja": "精神医学"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/research_interests/6319993",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0166380/research_interests",
                    "rm:id": "6319993",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:31Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:31Z",
                    "keyword": {
                        "en": "Psychiatry"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0166380/research_areas",
            "@type": "research_areas",
            "@reverse": "https://api.researchmap.jp/read0166380",
            "total_items": 1,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0166380/research_areas/5488127",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0166380/research_areas",
                    "rm:id": "5488127",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:31Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:31Z",
                    "discipline_number": "A189",
                    "item_number": "A52030",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "精神神経科学",
                        "en": "Psychiatry"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0166380/awards",
            "@type": "awards",
            "@reverse": "https://api.researchmap.jp/read0166380",
            "total_items": 1,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0166380/awards/1412394",
                    "@type": "awards",
                    "@reverse": "https://api.researchmap.jp/read0166380/awards",
                    "rm:id": "1412394",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:31Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:31Z",
                    "award_name": {
                        "ja": "北海道知事賞"
                    },
                    "award_date": "2009",
                    "address_country": "JPN"
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0166380/misc",
            "@type": "misc",
            "@reverse": "https://api.researchmap.jp/read0166380",
            "total_items": 261,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260249",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260249",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-14T21:39:11Z",
                    "paper_title": {
                        "en": "Effect of explicit instruction on Japanese Verbal Learning Test in schizophrenia patients"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Naoki Hashimoto"
                            },
                            {
                                "name": "Mie Matsui"
                            },
                            {
                                "name": "Ichiro Kusumi"
                            },
                            {
                                "name": "Atsuhito Toyomaki"
                            },
                            {
                                "name": "Koki Ito"
                            },
                            {
                                "name": "Yuki Kako"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "After random assignment of 20 schizophrenia patients to either an explicit or normal instruction group, the Japanese Verbal Learning Test was administered to them. Results reveal that explicit instruction group patients demonstrated more improved memory performance using semantic clustering, suggesting that explicit and direct teaching facilitates patients&apos; learning of information. (C) 2010 Elsevier Ireland Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER IRELAND LTD"
                    },
                    "publication_date": "2011-07",
                    "publication_name": {
                        "en": "PSYCHIATRY RESEARCH"
                    },
                    "volume": "188",
                    "number": "2",
                    "starting_page": "289",
                    "ending_page": "290",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.psychres.2010.06.024"
                        ],
                        "issn": [
                            "0165-1781"
                        ],
                        "pm_id": [
                            "20630604"
                        ],
                        "wos_id": [
                            "WOS:000292674500019"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.psychres.2010.06.024",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/20630604",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000292674500019&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260247",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260247",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-13T20:01:17Z",
                    "paper_title": {
                        "en": "Long-term naturalistic follow-up of lithium augmentation: Relevance to bipolarity"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Takeshi Inoue"
                            },
                            {
                                "name": "Tomohiro Abekawa"
                            },
                            {
                                "name": "Shin Nakagawa"
                            },
                            {
                                "name": "Katsuji Suzuki"
                            },
                            {
                                "name": "Teruaki Tanaka"
                            },
                            {
                                "name": "Yuji Kitaichi"
                            },
                            {
                                "name": "Shuken Boku"
                            },
                            {
                                "name": "Yasuya Nakato"
                            },
                            {
                                "name": "Hiroyuki Toda"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "Background: Whether bipolarity (unrecognized bipolar disorder) is related to the treatment response to lithium augmentation in antidepressant-refractory depression remains unclear. This study of responders and non-responders to lithium augmentation of 29 antidepressant-refractory patients with major depression, whom we had studied during 1995-1997, compared the bipolar diagnosis at the follow-up based on diagnostic confirmation after long-term follow-up.\nMethods: Before being classified as stage 2 treatment-resistant depression, these patients had been treated adequately with at least two tricyclic or heterocyclic antidepressants from different pharmacological classes (a minimum of the equivalent of 150 mg of imipramine for 4 weeks). During 1995-1997, 29 patients received lithium augmentation. Their treatment responses were recorded. Mean follow-up was 8.0 years (range, 1-13 years). Bipolar conversion and full remission were evaluated.\nResults: After the long-term follow-up, diagnoses were changed to bipolar depression in 3 of 4 lithium responders and 3 of 25 lithium non-responders; lithium augmentation was more effective for unrecognized bipolar patients. Only the family history of bipolar disorder predicted subsequent bipolar conversion.\nLimitations: Treatment was not controlled in this naturalistic study, which had a small sample size.\nConclusions: Results of this long-term follow-up study suggest that bipolarity is related to a positive response to lithium augmentation in stage 2 treatment-resistant major depression. The family history of bipolar disorder suggests false unipolar depression, and therefore indicates lithium responders. (C) 2010 Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2011-03",
                    "publication_name": {
                        "en": "JOURNAL OF AFFECTIVE DISORDERS"
                    },
                    "volume": "129",
                    "number": "1-3",
                    "starting_page": "64",
                    "ending_page": "67",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.jad.2010.08.022"
                        ],
                        "issn": [
                            "0165-0327"
                        ],
                        "pm_id": [
                            "20837361"
                        ],
                        "wos_id": [
                            "WOS:000288293400008"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.jad.2010.08.022",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/20837361",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000288293400008&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260246",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260246",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-13T00:50:21Z",
                    "paper_title": {
                        "ja": "Risperidone oral solution versus standard tablets for the acute treatment of patients with schizophrenia: Lack of difference in effectiveness.”",
                        "en": "Risperidone oral solution versus standard tablets for the acute treatment of patients with schizophrenia"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "KUSUMI Ichiro"
                            },
                            {
                                "name": "KOYAMA Tsukasa"
                            },
                            {
                                "name": "HONDA Minoru"
                            },
                            {
                                "name": "ITO Koichi"
                            },
                            {
                                "name": "KUMAZAWA Yukie"
                            },
                            {
                                "name": "UEMURA Keiichi"
                            },
                            {
                                "name": "KUMAZAWA Yukie"
                            },
                            {
                                "name": "ISHIKANE Tomohito"
                            },
                            {
                                "name": "NIIDE Yasushi"
                            }
                        ],
                        "en": [
                            {
                                "name": "Ichiro Kusumi"
                            },
                            {
                                "name": "Minoru Honda"
                            },
                            {
                                "name": "Koichi Ito"
                            },
                            {
                                "name": "Keiichi Uemura"
                            },
                            {
                                "name": "Yukie Kumazawa"
                            },
                            {
                                "name": "Tomohito Ishikane"
                            },
                            {
                                "name": "Yasushi Niide"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "The time required to attain the maximum plasma level of risperidone (RIS) is shorter for RIS oral solution (OS) than for RIS standard tablets (ST), although both forms have equal bioavailability. The objective of this study was to clarify whether RIS-OS shows a faster onset of efficacy and lower adverse events than RIS-ST. The two forms of risperidone were compared with respect to effectiveness including a speed of response, efficacy and tolerability. An open-label, 24-week, multicentre, randomized, flexible-dose study comparing the RIS-OS (mean dose, 3.7 mg; N = 44) to the RIS-ST (mean dose, 3.7 mg; N = 37) in acutely ill patients with schizophrenia showed no differences. Outcome measures included psychopathology, tolerability (extrapyramidal symptoms and serum prolactin), and Drug Attitude Inventory. This study was conducted between October 2006 and October 2008. Both RIS-OS- and RIS-ST-treated patients showed statistically significant reductions from the baseline in the mean scores of the Positive and Negative Syndrome Scale (PANSS)-total and PANSS-excite component, with no statistically significant differences between the treatment groups. The accumulated treatment response ratio was similar between the two groups. There was no significant difference in the Drug-Induced Extrapyramidal Symptom Scale score or serum prolactin increase between the treatment groups, but RIS-OS appeared to induce less serum prolactin increase than RIS-ST in drug-naive female patients. Because there is no theoretical reason why this should be so, these results will require confirmation from a double-blind study in a larger sample. No significant difference was observed in the subjective drug attitude between the two groups. The original hypothesis that RIS-OS shows an earlier onset of efficacy or less adverse events than RIS-ST was not supported in this study. Subsequent studies should carefully establish the differences among various forms of antipsychotic drugs. (C) 2010 Elsevier Inc. All rights reserved."
                    },
                    "publisher": {
                        "en": "PERGAMON-ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2011-03",
                    "publication_name": {
                        "ja": "Prog. Neuropsychopharmacol. Biol. Psychiatry",
                        "en": "PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY"
                    },
                    "volume": "35",
                    "number": "2",
                    "starting_page": "537",
                    "ending_page": "540",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "misc_type": "book_review",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.pnpbp.2010.12.010"
                        ],
                        "issn": [
                            "0278-5846"
                        ],
                        "pm_id": [
                            "21168464"
                        ],
                        "wos_id": [
                            "WOS:000289811200032"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.pnpbp.2010.12.010",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/21168464",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000289811200032&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260239",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260239",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-14T15:38:50Z",
                    "paper_title": {
                        "en": "Juvenile stress attenuates the dorsal hippocampal postsynaptic 5-HT1A receptor function in adult rats"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Hirokazu Matsuzaki"
                            },
                            {
                                "name": "Takeshi Izumi"
                            },
                            {
                                "name": "Takahiro Horinouchi"
                            },
                            {
                                "name": "Shuken Boku"
                            },
                            {
                                "name": "Takeshi Inoue"
                            },
                            {
                                "name": "Taku Yamaguchi"
                            },
                            {
                                "name": "Takayuki Yoshida"
                            },
                            {
                                "name": "Machiko Matsumoto"
                            },
                            {
                                "name": "Hiroko Togashi"
                            },
                            {
                                "name": "Soichi Miwa"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            },
                            {
                                "name": "Mitsuhiro Yoshioka"
                            }
                        ]
                    },
                    "description": {
                        "en": "Traumatic events in early life are associated with an increased risk of psychiatric diseases in adulthood. 5-hydroxytryptamine (5-HT)(1A) receptors play a pivotal role in the 5-HTergic mechanisms associated with the etiology of stress-related disorders.\nThe goal of the present study was to investigate whether juvenile stress influences emotional control via postsynaptic 5-HT1A receptor in the hippocampus and amygdala using contextual fear conditioning test in adult rats.\nThe rats were subjected to aversive footshock (FS) during the third week of the postnatal period (3wFS group). During the postadolescent period (10-14 weeks postnatal), experiments were performed.\nThe systemic administration of the 5-HT1A receptor agonist R-(+)-8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) (0.2 mg/kg, i.p.) attenuated the freezing behavior in the non-FS group, but not in the 3wFS group. The bilateral local injection of 8-OH-DPAT (1 mu g/side) into the amygdala decreased the freezing behavior in the non-FS group and the 3wFS group. However, the local injection of 8-OH-DPAT (1 mu g/side) into the hippocampus decreased the freezing behavior in the non-FS group, but not in the 3wFS group. In a 5-HT1A receptor binding study, the Bmax of the 3wFS group decreased in the dorsal hippocampus, but not the amygdala in comparison with the non-FS group.\nThe juvenile stress attenuated the hippocampal postsynaptic 5-HT1A receptor function in context-dependent conditioned fear."
                    },
                    "publisher": {
                        "en": "SPRINGER"
                    },
                    "publication_date": "2011-03",
                    "publication_name": {
                        "en": "PSYCHOPHARMACOLOGY"
                    },
                    "volume": "214",
                    "number": "1",
                    "starting_page": "329",
                    "ending_page": "337",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1007/s00213-010-1987-4"
                        ],
                        "issn": [
                            "0033-3158"
                        ],
                        "pm_id": [
                            "20714708"
                        ],
                        "e_issn": [
                            "1432-2072"
                        ],
                        "wos_id": [
                            "WOS:000287759300026"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1007/s00213-010-1987-4",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/20714708",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000287759300026&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260284",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260284",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2022-06-29T01:58:17Z",
                    "paper_title": {
                        "ja": "三環系抗うつ薬から選択的セロトニン再取り込み阻害薬へ置換した後に認知機能が改善したうつ病の１例"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "豊島 邦義"
                            },
                            {
                                "name": "清水 祐輔"
                            },
                            {
                                "name": "三井 信幸"
                            },
                            {
                                "name": "藤井 泰"
                            },
                            {
                                "name": "賀古 勇輝"
                            },
                            {
                                "name": "田中 輝明"
                            },
                            {
                                "name": "朝倉 聡"
                            },
                            {
                                "name": "北川 信樹"
                            },
                            {
                                "name": "小山 司"
                            }
                        ]
                    },
                    "description": {
                        "ja": "三環系抗うつ薬からSSRIへ置換した後、様々な神経認知機能が改善し、職場に適応するなど社会機能回復を認めた大うつ病性障害(MDD)の1例(53歳男性)について報告した。本例のように、抑うつ症状改善後、社会機能障害をきたしてはじめて認知機能障害が疑われるMDD症例は少なくないが、認知機能検査を施行することで、臨床場面では検出困難な軽微な認知機能障害を検出することが可能であると思われた。障害の要因については、疾病そのものの経過や症状レベル、薬剤の影響など様々な側面を考慮する必要があるが、MDDの維持療法を行う際には、認知機能を考慮しながら薬剤変更を試みることには価値があると考えられた。"
                    },
                    "publisher": {
                        "ja": "(有)科学評論社"
                    },
                    "publication_date": "2011",
                    "publication_name": {
                        "ja": "精神科"
                    },
                    "volume": "18",
                    "number": "2",
                    "starting_page": "238",
                    "ending_page": "243",
                    "languages": [
                        "jpn"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "1347-4790"
                        ],
                        "jamas_id": [
                            "2011193105"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "url",
                            "@id": "https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2011&ichushi_jid=J03789&link_issn=&doc_id=20110307160021&doc_link_id=40018703252&url=https%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F40018703252&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260248",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260248",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-12T17:48:55Z",
                    "paper_title": {
                        "en": "Effects of mood stabilizers on adult dentate gyrus-derived neural precursor cells"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Shuken Boku"
                            },
                            {
                                "name": "Shin Nakagawa"
                            },
                            {
                                "name": "Takahiro Masuda"
                            },
                            {
                                "name": "Hiroyuki Nishikawa"
                            },
                            {
                                "name": "Akiko Kato"
                            },
                            {
                                "name": "Hiroyuki Toda"
                            },
                            {
                                "name": "Ning Song"
                            },
                            {
                                "name": "Yuji Kitaichi"
                            },
                            {
                                "name": "Takeshi Inoue"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "Neurogenesis in the adult dentate gyrus (DG) is considered to be partly involved in the action of mood stabilizers. However, it remains unclear how mood stabilizers affect neural precursor cells in adult DG. We have established a culture system of adult rat DG-derived neural precursor cells (ADP) and have shown that lithium, a mood stabilizer, and dexamethasone, an agonist of glucocorticoid receptor, reciprocally regulate ADP proliferation. Neurogenesis constitutes not only proliferation of neural precursor cells but also apoptosis and differentiation. To develop further understanding of mood stabilizer effects on neural precursor cells in adult DG, we investigated and compared the effects of four common mood stabilizers lithium, valproate, carbamazepine, and lamotrigine on ADP proliferation, apoptosis, and differentiation. ADP proliferation, decreased by dexamethasone, was examined using Alamar Blue assay. Using TUNEL assay, ADP apoptosis induced by staurosporine was examined. The differentiated ADP induced by retinoic acid was characterized by immunostaining with anti-GFAP or anti-Tuj1 antibody. Lithium and valproate, but not carbamazepine and lamotrigine, recovered ADP proliferation decreased by dexamethasone. All four mood stabilizers decreased ADP apoptosis. Retinoic acid differentiated ADP into both neurons and astrocytes. Lithium and carbamazepine increased the ratio of neurons and decreased that of astrocytes. However, valproate and lamotrigine increased the ratio of astrocytes and decreased that of neurons. Therefore, these four stabilizers exhibited both common and differential effects on ADP proliferation, apoptosis, and differentiation. (C) 2010 Elsevier Inc. All rights reserved."
                    },
                    "publisher": {
                        "en": "PERGAMON-ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2011-01",
                    "publication_name": {
                        "en": "PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY"
                    },
                    "volume": "35",
                    "number": "1",
                    "starting_page": "111",
                    "ending_page": "117",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "misc_type": "book_review",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "10029785751"
                        ],
                        "doi": [
                            "10.1016/j.pnpbp.2010.09.019"
                        ],
                        "issn": [
                            "0278-5846"
                        ],
                        "pm_id": [
                            "20888882"
                        ],
                        "wos_id": [
                            "WOS:000287271400017"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/10029785751",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.pnpbp.2010.09.019",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/20888882",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000287271400017&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260237",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260237",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-22T16:18:15Z",
                    "paper_title": {
                        "en": "Pramipexole for stage 2 treatment-resistant major depression: An open study"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Takeshi Inoue"
                            },
                            {
                                "name": "Yuji Kitaichi"
                            },
                            {
                                "name": "Takuya Masui"
                            },
                            {
                                "name": "Shin Nakagawa"
                            },
                            {
                                "name": "Shuken Boku"
                            },
                            {
                                "name": "Teruaki Tanaka"
                            },
                            {
                                "name": "Katsuji Suzuki"
                            },
                            {
                                "name": "Yasuya Nakato"
                            },
                            {
                                "name": "Reiko Usui"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "Objective: To examine the effectiveness and safety of adjunctive pramipexole in the treatment of stage 2 treatment-resistant major depressive disorder.\nMethods: This study included patients with moderate or non-psychotic severe major depressive disorder according to DSM-IV-TR criteria despite at least two adequate treatment trials with antidepressants from different pharmacological classes. Pramipexole 0.25 to 2 mg daily was added to antidepressant therapy. Previous treatments were continued unchanged, but no new treatments were allowed. We conducted assessments at baseline and at weeks 2, 4, 6, and 8. We defined response as a 50% or greater reduction on the Montgomery-Asberg Depression Rating Scale (MADRS).\nResults: Ten patients (4 men, 6 women) aged 43.7 +/- 11.4 years received pramipexole at mean dose of 1.3 +/- 0.6 mg/d. Mean MADRS scores improved significantly from baseline to endpoint (mean differences = 11.4, 95% CI [4.1, 18.7], P = 0.0064). At the endpoint, six of 10 (60%) were responders on MADRS (&gt;= 50% reduction). Two patients (20%) terminated early due to mild somatic and psychiatric adverse effects.\nConclusion: These preliminary data suggest that the addition of pramipexole to antidepressant treatment may be effective and well tolerated in patients with stage 2 treatment-resistant major depressive disorder. (C) 2010 Elsevier Inc. All rights reserved."
                    },
                    "publisher": {
                        "en": "PERGAMON-ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2010-12",
                    "publication_name": {
                        "en": "PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY"
                    },
                    "volume": "34",
                    "number": "8",
                    "starting_page": "1446",
                    "ending_page": "1449",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "misc_type": "book_review",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.pnpbp.2010.07.035"
                        ],
                        "issn": [
                            "0278-5846"
                        ],
                        "pm_id": [
                            "20708060"
                        ],
                        "wos_id": [
                            "WOS:000285948800013"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.pnpbp.2010.07.035",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/20708060",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000285948800013&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260231",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260231",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-22T16:18:15Z",
                    "paper_title": {
                        "en": "Pramipexole for stage 2 treatment-resistant major depression: An open study"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Takeshi Inoue"
                            },
                            {
                                "name": "Yuji Kitaichi"
                            },
                            {
                                "name": "Takuya Masui"
                            },
                            {
                                "name": "Shin Nakagawa"
                            },
                            {
                                "name": "Shuken Boku"
                            },
                            {
                                "name": "Teruaki Tanaka"
                            },
                            {
                                "name": "Katsuji Suzuki"
                            },
                            {
                                "name": "Yasuya Nakato"
                            },
                            {
                                "name": "Reiko Usui"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "Objective: To examine the effectiveness and safety of adjunctive pramipexole in the treatment of stage 2 treatment-resistant major depressive disorder.\nMethods: This study included patients with moderate or non-psychotic severe major depressive disorder according to DSM-IV-TR criteria despite at least two adequate treatment trials with antidepressants from different pharmacological classes. Pramipexole 0.25 to 2 mg daily was added to antidepressant therapy. Previous treatments were continued unchanged, but no new treatments were allowed. We conducted assessments at baseline and at weeks 2, 4, 6, and 8. We defined response as a 50% or greater reduction on the Montgomery-Asberg Depression Rating Scale (MADRS).\nResults: Ten patients (4 men, 6 women) aged 43.7 +/- 11.4 years received pramipexole at mean dose of 1.3 +/- 0.6 mg/d. Mean MADRS scores improved significantly from baseline to endpoint (mean differences = 11.4, 95% CI [4.1, 18.7], P = 0.0064). At the endpoint, six of 10 (60%) were responders on MADRS (&gt;= 50% reduction). Two patients (20%) terminated early due to mild somatic and psychiatric adverse effects.\nConclusion: These preliminary data suggest that the addition of pramipexole to antidepressant treatment may be effective and well tolerated in patients with stage 2 treatment-resistant major depressive disorder. (C) 2010 Elsevier Inc. All rights reserved."
                    },
                    "publisher": {
                        "en": "PERGAMON-ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2010-12",
                    "publication_name": {
                        "en": "PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY"
                    },
                    "volume": "34",
                    "number": "8",
                    "starting_page": "1446",
                    "ending_page": "1449",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "misc_type": "book_review",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.pnpbp.2010.07.035"
                        ],
                        "issn": [
                            "0278-5846"
                        ],
                        "pm_id": [
                            "20708060"
                        ],
                        "wos_id": [
                            "WOS:000285948800013"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.pnpbp.2010.07.035",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/20708060",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000285948800013&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260241",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260241",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-21T21:37:48Z",
                    "paper_title": {
                        "en": "Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Yuji Kitaichi"
                            },
                            {
                                "name": "Takeshi Inoue"
                            },
                            {
                                "name": "Shin Nakagawa"
                            },
                            {
                                "name": "Shuken Boku"
                            },
                            {
                                "name": "Aya Kakuta"
                            },
                            {
                                "name": "Takeshi Izumi"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "Selective serotonin reuptake inhibitors (SSRIs) are a first-line treatment for depression. Recent reports in the literature describe differences in antidepressant effects among SSRIs. Although each SSRI apparently has different pharmacological actions aside from serotonin reuptake inhibition, the relations between antidepressant effects and unique pharmacological properties in respective SSRIs remain unclear. This study was designed to compare abilities of three systemically administered SSRIs to increase the extracellular levels of serotonin, dopamine, and noradrenaline acutely in three brain regions of male Sprague-Dawley rats. We examined effects of sertraline, fluvoxamine, and paroxetine on extracellular serotonin, dopamine, and noradrenaline levels in the medial prefrontal cortex, nucleus accumbens and striatum of rats using in vivo microdialysis. Dialysate samples were collected in sample vials every 20 min for 460 min. Extracellular serotonin, dopamine, and noradrenaline levels were determined using high-performance liquid chromatography with electrochemical detection. All SSRI administrations increased extracellular serotonin levels in all regions. Only sertraline administration increased extracellular dopamine concentrations in the nucleus accumbens and striatum. All SSRI administrations increased extracellular noradrenaline levels in the nucleus accumbens, although fluvoxamine was less effective. These results suggest that neurochemical differences account for the differences in clinical antidepressant effects among SSRIs. (c) 2010 Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2010-11",
                    "publication_name": {
                        "en": "EUROPEAN JOURNAL OF PHARMACOLOGY"
                    },
                    "volume": "647",
                    "number": "1-3",
                    "starting_page": "90",
                    "ending_page": "96",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.ejphar.2010.08.026"
                        ],
                        "issn": [
                            "0014-2999"
                        ],
                        "pm_id": [
                            "20816814"
                        ],
                        "wos_id": [
                            "WOS:000283835400012"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.ejphar.2010.08.026",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/20816814",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000283835400012&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260233",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260233",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-21T21:37:48Z",
                    "paper_title": {
                        "en": "Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Yuji Kitaichi"
                            },
                            {
                                "name": "Takeshi Inoue"
                            },
                            {
                                "name": "Shin Nakagawa"
                            },
                            {
                                "name": "Shuken Boku"
                            },
                            {
                                "name": "Aya Kakuta"
                            },
                            {
                                "name": "Takeshi Izumi"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "Selective serotonin reuptake inhibitors (SSRIs) are a first-line treatment for depression. Recent reports in the literature describe differences in antidepressant effects among SSRIs. Although each SSRI apparently has different pharmacological actions aside from serotonin reuptake inhibition, the relations between antidepressant effects and unique pharmacological properties in respective SSRIs remain unclear. This study was designed to compare abilities of three systemically administered SSRIs to increase the extracellular levels of serotonin, dopamine, and noradrenaline acutely in three brain regions of male Sprague-Dawley rats. We examined effects of sertraline, fluvoxamine, and paroxetine on extracellular serotonin, dopamine, and noradrenaline levels in the medial prefrontal cortex, nucleus accumbens and striatum of rats using in vivo microdialysis. Dialysate samples were collected in sample vials every 20 min for 460 min. Extracellular serotonin, dopamine, and noradrenaline levels were determined using high-performance liquid chromatography with electrochemical detection. All SSRI administrations increased extracellular serotonin levels in all regions. Only sertraline administration increased extracellular dopamine concentrations in the nucleus accumbens and striatum. All SSRI administrations increased extracellular noradrenaline levels in the nucleus accumbens, although fluvoxamine was less effective. These results suggest that neurochemical differences account for the differences in clinical antidepressant effects among SSRIs. (c) 2010 Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2010-11",
                    "publication_name": {
                        "en": "EUROPEAN JOURNAL OF PHARMACOLOGY"
                    },
                    "volume": "647",
                    "number": "1-3",
                    "starting_page": "90",
                    "ending_page": "96",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.ejphar.2010.08.026"
                        ],
                        "issn": [
                            "0014-2999"
                        ],
                        "pm_id": [
                            "20816814"
                        ],
                        "wos_id": [
                            "WOS:000283835400012"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.ejphar.2010.08.026",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/20816814",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000283835400012&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260244",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260244",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-21T13:01:19Z",
                    "paper_title": {
                        "en": "Lamotrigine blocks the initiation and expression of repeated high-dose methamphetamine-induced prepulse inhibition deficit in rats"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Yasuya Nakato"
                            },
                            {
                                "name": "Tomohiro Abekawa"
                            },
                            {
                                "name": "Koki Ito"
                            },
                            {
                                "name": "Takeshi Inoue"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "Our group developed a new psychostimulant animal model reflecting some clinical aspects of schizophrenia better than the conventional model does. In this model, long-lasting prepulse inhibition (PPI) deficit at the basement state is induced via repeated administration of methamphetamine (METH, 2.5 mg/kg) without challenge injection of this psychostimulant. This study elucidates the effects of lamotrigine (LTG, 30 mg/kg) on the initiation and expression of a steady-state PPI deficit induced by the repeated METH administration. We assessed the effect of coadministration of LTG and METH on the initiation of PPI deficit. The LTG was injected 120 min after each METH injection for 5 times on every alternate day and for an additional 5 times every day, amounting to a total of 10 times. After 11-13 days of the withdrawal period, we measured PPI using the SR-LAB system. Using other animals after 20 min of LTG injection, we subsequently examined the effect of a single injection of LTG on the expression of PPI deficit caused by the repeated METH administration. The LTG blocked the initiation of PPI deficit induced by the repeated METH administration at 68 dB of prepulse intensity, but had no effect on the startle amplitude. The LTG prevented the initiation and expression of neuroplastic PPI deficit detected at the baseline state without any METH challenge injection, which was induced by the repeated administration of this psychostimulant. Results suggest that LTG is useful for blocking progressive deterioration of neurocognitive function and recovering the neurocognitive deficit in schizophrenia. (C) 2010 Elsevier Ireland Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER IRELAND LTD"
                    },
                    "publication_date": "2010-09",
                    "publication_name": {
                        "en": "NEUROSCIENCE LETTERS"
                    },
                    "volume": "481",
                    "number": "3",
                    "starting_page": "183",
                    "ending_page": "187",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "120002386834"
                        ],
                        "doi": [
                            "10.1016/j.neulet.2010.07.002"
                        ],
                        "issn": [
                            "0304-3940"
                        ],
                        "pm_id": [
                            "20621163"
                        ],
                        "wos_id": [
                            "WOS:000281220600011"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/120002386834",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.neulet.2010.07.002",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/20621163",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000281220600011&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260238",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260238",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-23T08:04:50Z",
                    "paper_title": {
                        "en": "SSR504734, a glycine transporter-1 inhibitor, attenuates acquisition and expression of contextual conditioned fear in rats"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Hiroyuki Nishikawa"
                            },
                            {
                                "name": "Takeshi Inoue"
                            },
                            {
                                "name": "Takeshi Izumi"
                            },
                            {
                                "name": "Shin Nakagawa"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "Conditioned stress-induced freezing has been used as an indicator of anxiety in rodents to evaluate the anxiolytic effects of various compounds. However, the role of glycinergic neurotransmission in fear conditioning is not well understood. In this study, we investigated the effects of a selective glycine transporter-1 inhibitor, SSR504734, on contextual fear conditioning. In a fear acquisition experiment, rats were administered SSR504734 (3-30 mg/kg, intraperitoneal) 1 h before fear conditioning (i.e. inescapable footshock). Twenty-four hours after fear conditioning, the rats were placed in the experimental chamber without footshock, and freezing behavior was observed. SSR504734 (30 mg/kg) significantly inhibited contextual conditioned freezing. In a fear expression experiment, rats were administered SSR504734 (3-30 mg/kg, intraperitoneal) 23 h after fear conditioning and were tested 1 h after injection. SSR504734 (30 mg/kg) significantly inhibited contextual conditioned freezing. These findings indicate that SSR504734 attenuates both the acquisition and expression of contextual conditioned fear, and suggest that glycinergic neurotransmission may play an important role in conditioned fear. Behavioural Pharmacology 21:576-579 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins."
                    },
                    "publisher": {
                        "en": "LIPPINCOTT WILLIAMS & WILKINS"
                    },
                    "publication_date": "2010-09",
                    "publication_name": {
                        "en": "BEHAVIOURAL PHARMACOLOGY"
                    },
                    "volume": "21",
                    "number": "5-6",
                    "starting_page": "576",
                    "ending_page": "579",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1097/FBP.0b013e32833d419d"
                        ],
                        "issn": [
                            "0955-8810"
                        ],
                        "wos_id": [
                            "WOS:000281119000021"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1097/FBP.0b013e32833d419d",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000281119000021&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260232",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260232",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-23T08:04:50Z",
                    "paper_title": {
                        "en": "SSR504734, a glycine transporter-1 inhibitor, attenuates acquisition and expression of contextual conditioned fear in rats"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Hiroyuki Nishikawa"
                            },
                            {
                                "name": "Takeshi Inoue"
                            },
                            {
                                "name": "Takeshi Izumi"
                            },
                            {
                                "name": "Shin Nakagawa"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "Conditioned stress-induced freezing has been used as an indicator of anxiety in rodents to evaluate the anxiolytic effects of various compounds. However, the role of glycinergic neurotransmission in fear conditioning is not well understood. In this study, we investigated the effects of a selective glycine transporter-1 inhibitor, SSR504734, on contextual fear conditioning. In a fear acquisition experiment, rats were administered SSR504734 (3-30 mg/kg, intraperitoneal) 1 h before fear conditioning (i.e. inescapable footshock). Twenty-four hours after fear conditioning, the rats were placed in the experimental chamber without footshock, and freezing behavior was observed. SSR504734 (30 mg/kg) significantly inhibited contextual conditioned freezing. In a fear expression experiment, rats were administered SSR504734 (3-30 mg/kg, intraperitoneal) 23 h after fear conditioning and were tested 1 h after injection. SSR504734 (30 mg/kg) significantly inhibited contextual conditioned freezing. These findings indicate that SSR504734 attenuates both the acquisition and expression of contextual conditioned fear, and suggest that glycinergic neurotransmission may play an important role in conditioned fear. Behavioural Pharmacology 21:576-579 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins."
                    },
                    "publisher": {
                        "en": "LIPPINCOTT WILLIAMS & WILKINS"
                    },
                    "publication_date": "2010-09",
                    "publication_name": {
                        "en": "BEHAVIOURAL PHARMACOLOGY"
                    },
                    "volume": "21",
                    "number": "5-6",
                    "starting_page": "576",
                    "ending_page": "579",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1097/FBP.0b013e32833d419d"
                        ],
                        "issn": [
                            "0955-8810"
                        ],
                        "wos_id": [
                            "WOS:000281119000021"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1097/FBP.0b013e32833d419d",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000281119000021&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260240",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260240",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-06-09T15:45:33Z",
                    "paper_title": {
                        "ja": "Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in β-phenylethylamine.",
                        "en": "Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine."
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "KITAICHI Y"
                            },
                            {
                                "name": "KITAICHI Y"
                            },
                            {
                                "name": "INOUE T"
                            },
                            {
                                "name": "NAKAGAWA S"
                            },
                            {
                                "name": "BOKU S"
                            },
                            {
                                "name": "KOYAMA T"
                            },
                            {
                                "name": "IZUMI T"
                            }
                        ],
                        "en": [
                            {
                                "name": "Yuji Kitaichi"
                            },
                            {
                                "name": "Takeshi Inoue"
                            },
                            {
                                "name": "Shin Nakagawa"
                            },
                            {
                                "name": "Shuken Boku"
                            },
                            {
                                "name": "Takeshi Izumi"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "Monoamine oxidase inhibitors (MAO inhibitors) have been widely used as antidepressants. However, it remains unclear whether a difference exists between non-selective MAO inhibitors and selective MAO-A inhibitors in terms of their antidepressant effects. Using in vivo microdialysis methods, we measured extracellular noradrenaline and serotonin levels following administration of Ro 41-1049, a reversible MAO-A inhibitor and/or lazabemide, a reversible MAO-B inhibitor in the medial prefrontal cortex (mPFC) of rats. We examined the effect of local infusion of beta-phenylethylamine to the mPFC of rats on extracellular noradrenaline and serotonin levels. Furthermore, the concentrations of beta-phenylethylamine in the tissue of the mPFC after combined treatment with Ro 41-1049 and lazabemide were measured. The Ro 41-1049 alone and the combined treatment significantly increased extracellular noradrenaline levels compared with vehicle and lazabemide alone. Furthermore, the combined treatment increased noradrenaline levels significantly more than Ro 41-1049 alone did. The Ro 41-1049 alone and the combined treatment significantly increased extracellular serotonin levels compared with vehicle and lazabemide alone, but no difference in serotonin levels was found between the combined treatment group and the Ro 41-1049 group. Local infusion of low-dose beta-phenylethylamine increased extracellular noradrenaline levels, but not that of serotonin. Only the combined treatment significantly increased beta-phenylethylamine levels in tissues of the mPFC. Our results suggest that the combined treatment with a MAO-A inhibitor and a MAO-B inhibitor strengthens antidepressant effects because the combined treatment increases extracellular noradrenaline levels more than a MAO-A inhibitor alone through increases in beta-phenylethylamine."
                    },
                    "publication_date": "2010-07-10",
                    "publication_name": {
                        "ja": "Eur J Pharmacol.",
                        "en": "European journal of pharmacology"
                    },
                    "volume": "637",
                    "number": "1-3",
                    "starting_page": "77",
                    "ending_page": "82",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "misc_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "120002261718"
                        ],
                        "doi": [
                            "10.1016/j.ejphar.2010.04.014"
                        ],
                        "issn": [
                            "0014-2999"
                        ],
                        "pm_id": [
                            "20406628"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/120002261718",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.ejphar.2010.04.014",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/20406628",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260234",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260234",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-23T09:44:10Z",
                    "paper_title": {
                        "ja": "Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in β-phenylethylamine",
                        "en": "Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "KITAICHI Y"
                            },
                            {
                                "name": "KITAICHI Y"
                            },
                            {
                                "name": "INOUE T"
                            },
                            {
                                "name": "NAKAGAWA S"
                            },
                            {
                                "name": "BOKU S"
                            },
                            {
                                "name": "KOYAMA T"
                            },
                            {
                                "name": "IZUMI T"
                            }
                        ],
                        "en": [
                            {
                                "name": "Yuji Kitaichi"
                            },
                            {
                                "name": "Takeshi Inoue"
                            },
                            {
                                "name": "Shin Nakagawa"
                            },
                            {
                                "name": "Shuken Boku"
                            },
                            {
                                "name": "Takeshi Izumi"
                            },
                            {
                                "name": "Tsukasa Koyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "Monoamine oxidase inhibitors (MAO inhibitors) have been widely used as antidepressants. However, it remains unclear whether a difference exists between non-selective MAO inhibitors and selective MAO-A inhibitors in terms of their antidepressant effects. Using in vivo microdialysis methods, we measured extracellular noradrenaline and serotonin levels following administration of Ro 41-1049, a reversible MAO-A inhibitor and/or lazabemide, a reversible MAO-B inhibitor in the medial prefrontal cortex (mPFC) of rats. We examined the effect of local infusion of beta-phenylethylamine to the mPFC of rats on extracellular noradrenaline and serotonin levels. Furthermore, the concentrations of beta-phenylethylamine in the tissue of the mPFC after combined treatment with Ro 41-1049 and lazabemide were measured. The Ro 41-1049 alone and the combined treatment significantly increased extracellular noradrenaline levels compared with vehicle and lazabemide alone. Furthermore, the combined treatment increased noradrenaline levels significantly more than Ro 41-1049 alone did. The Ro 41-1049 alone and the combined treatment significantly increased extracellular serotonin levels compared with vehicle and lazabemide alone, but no difference in serotonin levels was found between the combined treatment group and the Ro 41-1049 group. Local infusion of low-dose beta-phenylethylamine increased extracellular noradrenaline levels, but not that of serotonin. Only the combined treatment significantly increased beta-phenylethylamine levels in tissues of the mPFC. Our results suggest that the combined treatment with a MAO-A inhibitor and a MAO-B inhibitor strengthens antidepressant effects because the combined treatment increases extracellular noradrenaline levels more than a MAO-A inhibitor alone through increases in beta-phenylethylamine. (C) 2010 Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2010-07",
                    "publication_name": {
                        "ja": "European Journal of Pharmacology",
                        "en": "EUROPEAN JOURNAL OF PHARMACOLOGY"
                    },
                    "volume": "637",
                    "number": "1-3",
                    "starting_page": "77",
                    "ending_page": "82",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "120002261718"
                        ],
                        "doi": [
                            "10.1016/j.ejphar.2010.04.014"
                        ],
                        "issn": [
                            "0014-2999"
                        ],
                        "pm_id": [
                            "20406628"
                        ],
                        "wos_id": [
                            "WOS:000278878900011"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/120002261718",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.ejphar.2010.04.014",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/20406628",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000278878900011&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260227",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260227",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-06-09T19:15:10Z",
                    "paper_title": {
                        "ja": "気分障害圏患者における副作用に対する認知とコンプライアンスへの影響、および心理検査との相関性の検討"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "久保田 康生"
                            },
                            {
                                "name": "木村 俊也"
                            },
                            {
                                "name": "渡邉 紀子"
                            },
                            {
                                "name": "大崎 明美"
                            },
                            {
                                "name": "鈴木 克治"
                            },
                            {
                                "name": "菅原 満"
                            },
                            {
                                "name": "小山 司"
                            },
                            {
                                "name": "井関 健"
                            }
                        ]
                    },
                    "description": {
                        "ja": "気分障害圏の患者において薬物治療は症状・機能回復、再発予防のため重要であるが、拒薬に至る患者は4割といわれている。今回、患者に対し薬物療法への認識や考え方についてアンケート調査を行った結果、41%の患者にて拒薬の経験が認められた。理由として、副作用を避けるためなど認識の低さが原因であった。薬剤師が伝えた情報と患者の理解に差がみられる場合もある。そこで、患者の認知や思考の特性を知ることは服薬指導を充実させる方法として重要と考え、認知や思考を含め広く心理機能を測定できるロールシャッハテストに着目した。ロールシャッハテストは7つのクラスターを基に解釈される心理検査であるが、そのなかから認知や思考に関与するZd、X-%、HVIの3種の指標を選択した。HVI陽性において、拒薬との相関性が認められた。HVI陰性においてもZd、X-%が期待値外の場合、治療薬の理解に影響を与える可能性が考えられた。(著者抄録)"
                    },
                    "publisher": {
                        "ja": "(一社)日本病院薬剤師会"
                    },
                    "publication_date": "2010-03",
                    "publication_name": {
                        "ja": "日本病院薬剤師会雑誌"
                    },
                    "volume": "46",
                    "number": "3",
                    "starting_page": "359",
                    "ending_page": "362",
                    "languages": [
                        "jpn"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "1341-8815"
                        ],
                        "jamas_id": [
                            "2010135502"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "jamas_url",
                            "@id": "https://search.jamas.or.jp/index.php?module=Default&action=Link&doc_id=20100311170006&url=http%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fdg4hppha%2F2010%2F004603%2F003%2F0359-0362%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260283",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260283",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2022-06-29T01:58:18Z",
                    "paper_title": {
                        "ja": "Neuropsychiatric SLEの治療において認知機能検査が有用であった2症例"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "賀古 勇輝"
                            },
                            {
                                "name": "藤井 泰"
                            },
                            {
                                "name": "橋本 直樹"
                            },
                            {
                                "name": "田中 輝明"
                            },
                            {
                                "name": "北川 信樹"
                            },
                            {
                                "name": "小山 司"
                            }
                        ]
                    },
                    "description": {
                        "ja": "全身性エリテマトーデス(SLE)に随伴した精神症状や認知機能障害の治療経過中、認知機能検査を施行し、治療法選択や効果判定の指標として有効であった2症例(21歳女、22歳女)について報告した。2例とも免疫学的指標や脳画像検査においてSLEの増悪を示唆する所見に乏しかったが、認知機能検査では実効機能や運動速度、注意機能など複数の認知領域で顕著な異常が認められた。ステロイドパルス療法およびバルプロ酸投与により精神症状や認知機能の改善を認め、その後施行した認知機能検査では改善が認められ、認知機能障害の改善を客観的に確認することができた。"
                    },
                    "publisher": {
                        "ja": "(株)アークメディア"
                    },
                    "publication_date": "2010",
                    "publication_name": {
                        "ja": "臨床精神医学"
                    },
                    "volume": "39",
                    "number": "10",
                    "starting_page": "1347",
                    "ending_page": "1354",
                    "languages": [
                        "jpn"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0300-032X"
                        ],
                        "jamas_id": [
                            "2011031599"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "url",
                            "@id": "https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2010&ichushi_jid=J01552&link_issn=&doc_id=20101018070011&doc_link_id=40017346707&url=https%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F40017346707&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif",
                            "is_downloadable": false
                        },
                        {
                            "label": "url",
                            "@id": "https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2010&ichushi_jid=J01552&link_issn=&doc_id=20101018070011&doc_link_id=%2Fao1clphd%2F2010%2F003910%2F011%2F1347-1354%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fao1clphd%2F2010%2F003910%2F011%2F1347-1354%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260282",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260282",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "paper_title": {
                        "ja": "Nueropsychhiatric SLEの治療において認知機能検査が有用であった2症例"
                    },
                    "publication_date": "2010",
                    "publication_name": {
                        "ja": "臨床精神医学"
                    },
                    "volume": "39",
                    "number": "10",
                    "starting_page": "1347",
                    "ending_page": "1354",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260245",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260245",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "paper_title": {
                        "ja": "痛覚による恐怖条件付けにおけるセロトニンの機能的役割"
                    },
                    "publication_date": "2010",
                    "publication_name": {
                        "ja": "医学のあゆみ"
                    },
                    "volume": "232",
                    "number": "1",
                    "starting_page": "75",
                    "ending_page": "29",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/misc/11260243",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0166380/misc",
                    "rm:id": "11260243",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "paper_title": {
                        "ja": "北海道内の精神科医を対象とした双極性障害の薬物療法に関するアンケート調査"
                    },
                    "publication_date": "2010",
                    "publication_name": {
                        "ja": "臨床精神薬理"
                    },
                    "volume": "13",
                    "starting_page": "2293",
                    "ending_page": "2303",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0166380/books_etc",
            "@type": "books_etc",
            "@reverse": "https://api.researchmap.jp/read0166380",
            "total_items": 6,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0166380/books_etc/8859495",
                    "@type": "books_etc",
                    "@reverse": "https://api.researchmap.jp/read0166380/books_etc",
                    "rm:id": "8859495",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "book_title": {
                        "ja": "脳とこころのプライマリケア"
                    },
                    "publisher": {
                        "ja": "株式会社シナジー"
                    },
                    "publication_date": "2010",
                    "referee": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/books_etc/8859494",
                    "@type": "books_etc",
                    "@reverse": "https://api.researchmap.jp/read0166380/books_etc",
                    "rm:id": "8859494",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "book_title": {
                        "ja": "子どもの不安障害と抑うつ"
                    },
                    "publisher": {
                        "ja": "中山書店"
                    },
                    "publication_date": "2010",
                    "referee": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/books_etc/8859493",
                    "@type": "books_etc",
                    "@reverse": "https://api.researchmap.jp/read0166380/books_etc",
                    "rm:id": "8859493",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "book_title": {
                        "ja": "子どもの心の診療シリーズ4. 子どもの不安障害と抑うつ"
                    },
                    "publisher": {
                        "ja": "中山書店"
                    },
                    "publication_date": "2010",
                    "referee": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/books_etc/8859492",
                    "@type": "books_etc",
                    "@reverse": "https://api.researchmap.jp/read0166380/books_etc",
                    "rm:id": "8859492",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "book_title": {
                        "ja": "統合失調症の薬物治療アルゴリズム、抗精神病薬の急性副作用"
                    },
                    "publisher": {
                        "ja": "医学書院"
                    },
                    "publication_date": "2006",
                    "referee": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/books_etc/8859491",
                    "@type": "books_etc",
                    "@reverse": "https://api.researchmap.jp/read0166380/books_etc",
                    "rm:id": "8859491",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "book_title": {
                        "ja": "TEXT BOOK女性心身医学"
                    },
                    "publisher": {
                        "ja": "永井書店"
                    },
                    "publication_date": "2006",
                    "referee": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/books_etc/8859490",
                    "@type": "books_etc",
                    "@reverse": "https://api.researchmap.jp/read0166380/books_etc",
                    "rm:id": "8859490",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "book_title": {
                        "ja": "統合失調症の薬物治療アルゴリズム"
                    },
                    "publisher": {
                        "ja": "医学書院"
                    },
                    "publication_date": "2006",
                    "referee": false
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0166380/association_memberships",
            "@type": "association_memberships",
            "@reverse": "https://api.researchmap.jp/read0166380",
            "total_items": 6,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0166380/association_memberships/7049881",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0166380/association_memberships",
                    "rm:id": "7049881",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "academic_society_name": {
                        "ja": "日本精神神経学会（評議員）"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/association_memberships/7049880",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0166380/association_memberships",
                    "rm:id": "7049880",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "academic_society_name": {
                        "ja": "日本生物学的精神医学会（評議員）"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/association_memberships/7049879",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0166380/association_memberships",
                    "rm:id": "7049879",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "academic_society_name": {
                        "ja": "日本神経精神薬理学会（評議員）"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/association_memberships/7049878",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0166380/association_memberships",
                    "rm:id": "7049878",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "academic_society_name": {
                        "ja": "日本神経化学会（評議員）"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/association_memberships/7049877",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0166380/association_memberships",
                    "rm:id": "7049877",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "academic_society_name": {
                        "ja": "日本心身医学会（理事）日本精神科診断学会（理事）"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0166380/association_memberships/7049876",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0166380/association_memberships",
                    "rm:id": "7049876",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "academic_society_name": {
                        "ja": "世界生物学的精神医学会"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0166380/research_projects",
            "@type": "research_projects",
            "@reverse": "https://api.researchmap.jp/read0166380",
            "total_items": 1,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0166380/research_projects/9967009",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0166380/research_projects",
                    "rm:id": "9967009",
                    "rm:user_id": "1000000115",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:creator_type": "institution",
                    "rm:created": "2012-04-27T17:41:34Z",
                    "rm:modifier_id": "client_id:xpnUVEDfT_lj31mM",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2012-04-27T17:41:34Z",
                    "research_project_title": {
                        "ja": "精神疾患の病態および向精神薬の作用機序に関する神経化学的研究"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                }
            ]
        }
    ]
}